Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
35.98 EUR | +3.53% | +17.62% | +1.41% |
May. 08 | Transcript : Lenzing Aktiengesellschaft, Q1 2024 Earnings Call, May 08, 2024 | |
May. 03 | Lenzing Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Weaknesses
- The company has insufficient levels of profitability.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.41% | 1.45B | B | ||
+24.29% | 5.73B | C | ||
+1.45% | 5.08B | C- | ||
+5.46% | 3.9B | C | ||
-1.88% | 2.07B | - | - | |
+0.63% | 1.59B | B+ | ||
-0.35% | 995M | - | ||
-10.86% | 960M | - | D+ | |
+1.34% | 631M | - | - | |
-23.02% | 468M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LNZ Stock
- Ratings Lenzing AG